NCT03081832View on ClinicalTrials.gov

Follow-up of Prader Willi Syndrome Infants Treated by Oxytocin and Comparison With Not-treated Infants.

NACompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

January 31, 2017

Primary Completion Date

May 31, 2018

Study Completion Date

December 31, 2018

Conditions
Prader-Willi Syndrome
Interventions
DRUG

Oxytocin

Infant included in the ancient study (repeated administrations of oxytocin in infants with Prader Willi Syndrome aged from 0 to 6 months)

OTHER

Control

Not treated.

Trial Locations (1)

31059

Centre de référence du syndrome de Prader-Willi Hôpital des Enfants, Toulouse

All Listed Sponsors
lead

University Hospital, Toulouse

OTHER

NCT03081832 - Follow-up of Prader Willi Syndrome Infants Treated by Oxytocin and Comparison With Not-treated Infants. | Biotech Hunter | Biotech Hunter